tiprankstipranks
Advertisement
Advertisement
Glaukos initiated with a Buy at H.C. Wainwright
PremiumThe FlyGlaukos initiated with a Buy at H.C. Wainwright
11d ago
Glaukos completes patient enrollment in Phase 2 study of GLK-321
Premium
The Fly
Glaukos completes patient enrollment in Phase 2 study of GLK-321
22d ago
Glaukos price target raised to $150 from $136 at Needham
Premium
The Fly
Glaukos price target raised to $150 from $136 at Needham
30d ago
Analyst Reiterates Buy on Glaukos, Citing Long-Term iDose Opportunity and Upcoming Epioxa-Driven Growth
PremiumRatingsAnalyst Reiterates Buy on Glaukos, Citing Long-Term iDose Opportunity and Upcoming Epioxa-Driven Growth
1M ago
Glaukos pullback due to concerns about iDose LCD, says William Blair
Premium
The Fly
Glaukos pullback due to concerns about iDose LCD, says William Blair
2M ago
Steven Lichtman Reiterates Buy on Glaukos, Citing Manageable Coverage Risk and Robust Multiyear iDose Growth Outlook
Premium
Ratings
Steven Lichtman Reiterates Buy on Glaukos, Citing Manageable Coverage Risk and Robust Multiyear iDose Growth Outlook
2M ago
Glaukos Corp. Earnings Call Signals Growth Momentum
PremiumCompany AnnouncementsGlaukos Corp. Earnings Call Signals Growth Momentum
3M ago
Glaukos price target raised to $153 from $134 at Goldman Sachs
Premium
The Fly
Glaukos price target raised to $153 from $134 at Goldman Sachs
3M ago
Glaukos price target raised to $170 from $160 at Stifel
Premium
The Fly
Glaukos price target raised to $170 from $160 at Stifel
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100